InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
3
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-36.2%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the complete record of transactions filed by Litchman Manuel MD, 董事长兼首席执行官. Director active across 1 company, notably Mustang Bio, INC.. Aggregated, 10 disclosures have been recorded. Split: 3 buys · 0 sell. Total volume traded: €340k. Activity tracked since 17 June 2021. The latest transaction was filed on 24 April 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Litchman Manuel MD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
19 股@ US$0.750.0003% mcap0.0% 占其流量COMMON STOCKSEC:0001104659-26-049430:0
27 股@ US$1.240.0% 占其流量COMMON STOCKSEC:0001104659-25-040237:0
1,248 股@ US$12.152.0% 占其流量Common StockSEC:0001104659-24-068409:0
1,396 股@ US$0.350.1% 占其流量Common StockSEC:0001104659-24-068411:0
5,000 股0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-23-079110:0
5,000 股@ US$0.7390.5% 占其流量COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-23-040934:0
标准退出：2022年6月16日 (T+90)
65,000 股@ US$2.2436.6% 占其流量COMMON STOCKSEC:0001104659-21-135706:0
标准退出：2022年1月25日 (T+90)
2,746 股@ US$2.581.7% 占其流量COMMON STOCKSEC:0001104659-21-119384:0
86,206 股@ US$2.9161.5% 占其流量COMMON STOCKSEC:0001104659-21-100783:0
标准退出：2021年10月28日 (T+90)
61,000 股0COMMON STOCKSEC:0001104659-21-090242:0
10 条申报中的 10 条
About Litchman Manuel MD
Litchman Manuel MD is President-Directeur Général and acts for Mustang Bio, INC., where his listed function is President, CEO and Interim CFO. He has 10 filings in total, and across the sampled recent filings, buy volume totals EUR 339775 with no reported sales, over the period from 2021-07-08 to 2026-04-27; the most frequent transaction nature shown is Tax withholding.
